Subtypes


Web

  • http://www.drugs.com/mtm/dexmethylphenidate.html
  • Dexmethylphenidate is a mild stimulant to the central nervous system.
  • http://www.medicines.org.uk/emc/medicine/22281
  • For the different dose regimens Afinitor is available as 2.5 mg, 5 mg and 10 mg tablets.
  • http://www.cancer.gov/about-cancer/treatment/drugs/everolimus/
  • This page contains brief information about everolimus and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
  • http://www.diagnosia.com/en/drug/afinitor-10-mg-tablets
  • Afinitor is an anticancer medicine containing the active substance everolimus.
  • http://www.wikidoc.org/index.php/Dexmethylphenidate
  • WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling.
  • http://www.uwhealth.org/health/topic/multum/focalin-xr/d04777a1.html
  • You should not use dexmethylphenidate if you have glaucoma, tics or Tourette's syndrome, or severe anxiety, tension, or agitation.
  • http://www.oncolink.org/treatment/article.cfm?c=2&id=450&aid=480
  • Everolimus is a type of targeted therapy.This means it works by targeting something specific to the cancer cells, therefore decreasing side effects caused by unwanted damage to the healthy cells.
  • http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Tre...
  • Everolimus is used to treat kidney cancer, that has spread and advanced pancreatic neuroendocrine cancer (pNET).
  • http://www.nps.org.au/medicines/cancers/other-anticancer-medicine...
  • Afinitor Tablets is a brand of medicine containing the active ingredient everolimus (other anticancer medicines).
  • http://keckmedicine.adam.com/content.aspx?productId=45&pid=45&gid=5738
  • There may be other brand names for this medicine.
  • 1 2 3 4 5 6 7 8 9

    News

    Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma
    Nature - Monday, October 8, 2018
    Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma
    Nature - Monday, October 8, 2018
    The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance
    Endocrinology-journals - Friday, August 31, 2018
    Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma
    Nature - Wednesday, May 9, 2018
    FDA Clears Everolimus Tablets for Seizures in Tuberous Sclerosis FDA Clears Everolimus Tablets for Seizures in Tuberous Sclerosis
    Med Worm - Thursday, April 12, 2018
    Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study
    Nature - Friday, April 6, 2018
    Cabozantinib Bests Everolimus in RCC with Bone Metastases (CME/CE)
    Medpage Today - Monday, January 15, 2018
    Everolimus With Trastuzumab and Paclitaxel for HER2+ MBC Everolimus With Trastuzumab and Paclitaxel for HER2+ MBC
    Med Worm - Wednesday, December 13, 2017
    Mid- and Long-Term Outcome Comparisons of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-Analysis
    Annals of Internal Medicine - Wednesday, October 18, 2017
    Dexmethylphenidate (Focalin XR) Tablet, Capsule for Exended-Release
    RXList - Wednesday, August 23, 2017
    Conversion From CNI to Everolimus After Kidney Transplant Conversion From CNI to Everolimus After Kidney Transplant
    Med Worm - Wednesday, August 16, 2017
    Nephrotic Syndrome Reported With Everolimus, Voriconazole
    Physicians Briefing - Saturday, July 8, 2017
    Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1
    Nature - Wednesday, June 14, 2017
    Temporal Trends in Adverse Events After Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent ImplantationClinical PerspectiveA Meta-Analysis of Randomized Controlled Trials
    American Heart Association - Wednesday, May 31, 2017
    Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy
    Oxford Journals - Friday, May 26, 2017
    Long-Lasting Effect of Everolimus in Tuberous Sclerosis
    RXList - Friday, May 12, 2017
    Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, e
    Oxford Journals - Tuesday, May 9, 2017
    Judge Rules for Novartis in Zortress Patent Infringement Suit, with a Caveat
    U.S. Food and Drug Administration - Tuesday, April 4, 2017
    MORE NEWS

    Videos

    Everolimus Medication Uses and Side Effects
         
    Everolimus is a prescription medication used to treat certain types of cancer in the pancreas, kidney, brain, and breast. http://www.rxwiki.com/Everolimus

    Managing the Toxicity of Everolimus in Breast Cancer
         
    In this discussion, panelists discuss unique strategies for managing toxicity related with everolimus, since stomatitis has a tendency of occurring very rapidly.

    Jose Baselga, MD, PhD: BOLERO-2 Findings Confirm Efficacy of Everolimus Plus Exemestane
         
    Dr. Jose Baselga discusses the exciting data for the HER2-negative breast cancer patient -- the BOLERO-2 trial released at the CTRC-AACR 34th Annual San Antonio Breast Cancer Symposium. Dr. Baselga is the Chief of the Division of Hematology/Oncology, A...

    Information for Afinitor a Prescription Medication Used to Treat Certain Types of Cancer
         
    http://www.rxwiki.com/afinitor https://www.youtube.com/watch?v=8q6iXxqUhQ4&list=PLXxn_pCvHVm7XKp6U5_K1B88bqvrJRjIg Afinitor is a prescription medication called a kinase inhibitor that is used to treat certain types of cancer in the pancreas, kidney,...

    Observational Studies in Patients with TSC
         
    Karen Keough, MD of Dell Children's Medical Center in Austin, TX is a leader in the management of children with tuberous sclerosis complex (TSC). in this interview, she talks about the observational studies she is involved with examing the efficacy of var...

    Tuberous Sclerosis: Study Shows Drug Can Shrink Tumors and Save Kidneys
         
    http://www.cincinnatichildrens.org/service/t/tuberous-sclerosis/default/ Misty Barnhart is a patient of the Tuberous Sclerosis Clinic at Cincinnati Children's. She was diagnosed with tuberous sclerosis complex at 14 and has been battling her illness ev...

    San Antonio Breast Cancer Symposium SABCS 2011
         
    San Antonio Breast Cancer Symposium (SABCS) 2011 preview by Sally Church, PhD of http://PharmaStrategyBlog.com This video discusses three clinical trials that will be presented at SABCS: BOLERO2, CLEOPATRA, NEOSPHERE and the impact positive data may ha...

    Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data
         
    Visit http://www.ecancer.org for more. Prof Osborne (Baylor College of Medicine, Houston, USA) provides his expert opinion to ecancertv on data presented by Prof Hurvitz at SABCS 2014 about the effects of daily everolimus plus weekly trastuzumab and pa...

    1 2 3 4 5 6 7 8 9

    Images

    Everolimus ball-and-stick.png
    769px Everolimus svg
    File:Dexmethylphenidate structure.svg
    97px Everolimus svg
    Chemical structures of everolimus and deforolimus
    Everolimus ball-and-stick.png
    en.wikipedia.org
    769px Everolimus svg
    en.wikipedia.org
    File:Dexmethylphenidate structure.svg
    en.wikipedia.org
    97px Everolimus svg
    en.wikipedia.org
    Chemical structures of everolimus and deforolimus
    en.wikipedia.org
    dexmethylphenidate 8
    dexmethylphenidate 2
    dexmethylphenidate 1
    zortress 05
    zortress 04
    dexmethylphenidate 8
    drugs.com
    dexmethylphenidate 2
    drugs.com
    dexmethylphenidate 1
    drugs.com
    zortress 05
    drugs.com
    zortress 04
    drugs.com
    zortress 03
    zortress 02
    zortress 01
    focalin xr 0a
    focalin xr 09
    zortress 03
    drugs.com
    zortress 02
    drugs.com
    zortress 01
    drugs.com
    focalin xr 0a
    drugs.com
    focalin xr 09
    drugs.com
    focalin xr 08
    focalin xr 07
    What to Expect When Starting AFINITOR
    Nearly twice as many people taking AFINITOR with exemestane had tumors that shrank or disappeared, or were stable for at least 24 weeks, than people taking exemestane alone.
    Image of Focalin XR 40 mg
    focalin xr 08
    drugs.com
    focalin xr 07
    drugs.com
    What to Expect When Starting AFINITOR
    webmd.com
    Nearly twice as many people taking AFINITOR with exemestane had tumors that shrank or disappeared, or were stable for at least 24 weeks, than people taking exemestane alone.
    webmd.com
    Image of Focalin XR 40 mg
    uwhealth.org
    Image of Focalin XR 35 mg
    Image of Focalin XR 25 mg
    Image of Dexmethylphenidate 5 mg-TEV
    Image of Dexmethylphenidate 2.5 mg-TEV
    Image of Dexmethylphenidate 10 mg-TEV
    Image of Focalin XR 35 mg
    uwhealth.org
    Image of Focalin XR 25 mg
    uwhealth.org
    Image of Dexmethylphenidate 5 mg-TEV
    uwhealth.org
    Image of Dexmethylphenidate 2.5 mg-TEV
    uwhealth.org
    Image of Dexmethylphenidate 10 mg-TEV
    uwhealth.org
    A growing cancer cell divides in two: mTOR inhibitors such as everolimus help regulate cellular processes in cancer.
    E7080 is a capsule and everolimus is a tablet.
    Serial computed tomography (CT) scans from a patient treated with the mammalian target of rapamycin (mTOR) inhibitor everolimus for metastatic renal cell carcinoma demonstrate a reduction in the size of a metastasis at the medial right lung base (A) but a
    Everolimus slows disease progression in advanced papillary kidney cancer patients
    Everolimus 11
    A growing cancer cell divides in two: mTOR inhibitors such as everolimus help regulate cellular processes in cancer.
    cancer.gov
    E7080 is a capsule and everolimus is a tablet.
    cancerresearchuk.org
    Serial computed tomography (CT) scans from a patient treated with the mammalian target of rapamycin (mTOR) inhibitor everolimus for metastatic renal cell carcinoma demonstrate a reduction in the size of a metastasis at the medial right lung base (A) but a
    nature.com
    Everolimus slows disease progression in advanced papillary kidney cancer patients
    health.am
    Everolimus 11
    wikidoc.org
    Everolimus 10
    Everolimus 09
    Everolimus 08
    Everolimus 07
    Everolimus 06
    Everolimus 10
    wikidoc.org
    Everolimus 09
    wikidoc.org
    Everolimus 08
    wikidoc.org
    Everolimus 07
    wikidoc.org
    Everolimus 06
    wikidoc.org
    Everolimus 05
    Everolimus 04
    Everolimus 03
    Everolimus 02
    Everolimus 01
    Everolimus 05
    wikidoc.org
    Everolimus 04
    wikidoc.org
    Everolimus 03
    wikidoc.org
    Everolimus 02
    wikidoc.org
    Everolimus 01
    wikidoc.org

    MORE IMAGES